VEGFR2 Kinase Inhibitor II T37079
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
500 μg | 288144-20-7 | ¥1,480.00 | 询底价 |
1 mg | 288144-20-7 | ¥2,760.00 | 询底价 |
Product Introduction
Bioactivity
英文名: VEGFR2 Kinase Inhibitor II
描述: Vascular endothelial growth factor receptor 2 (VEGFR2, also known as KDR and FLK1) is a receptor tyrosine kinase that regulates angiogenesis, vascular development, and embryonic hematopoiesis in response to VEGF isoforms A, C, and D. VEGFR2 kinase inhibitor II is a reversible, cell-permeable inhibitor of VEGFR2's kinase activity (IC50 = 70 nM). It less potently inhibits the platelet-derived growth factor receptor β (PDGFRβ; IC50 = 920 nM) and related receptor and non-receptor tyrosine kinases. VEGFR2 kinase inhibitor II blocks the growth of human umbilical vein endothelial cells stimulated with either VEGF or PDGF (IC50s = 110 nM and 2 μM, respectively).
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMF : 20 mg/mL
DMSO : 10 mg/mL
关键字: VEGFR2 Kinase Inhibitor II | VEGFR-2 Kinase Inhibitor II
VEGFR2 Kinase Inhibitor II T37079信息由TargetMol中国为您提供,如您想了解更多关于VEGFR2 Kinase Inhibitor II T37079报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途